We invest in research and development to improve the lives of patients and liberate healthcare resources through increased access to high-quality, affordable biologics.
Biologics have revolutionized the treatment and prevention of many disabling and life-threatening diseases. A biosimilar is a follow-on medicine of existing biologic when the patent has expired.
Analytical, preclinical and clinical pharmacokinetic/pharmacodynamic studies demonstrate that the active substance in the biosimilar medicine matches the reference medicine.
Biological medicines (or “biologics”) are innovative treatments that have transformed the lives of millions of patients with many disabling and life-threatening diseases.
